Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-Menopausal Patients

This study is ongoing, but not recruiting participants.

Study NCT00303524 Information provided by AstraZeneca

First Received: March 16, 2006 Last Updated: June 18, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	February 2009
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)